resources

Sotac Pharmaceuticals Ltd.

NSE: SOTAC

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

92.00+0.0 (+0.00%)

21 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Sotac Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2023	2024
Annual Reports	—	—
Quarterly Results	Sept Dec	Mar Jun Sept
Conference Calls	—	—
Presentations	—	—

Corporate Announcements and Regulatory Filings

Sotac Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under SEBI (Depositories and Participants) Regulations, 201812 Oct 2026
Sotac Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on September 30,2026.
Copy of Newspaper Publication12 Oct 2026
Sotac Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
Shareholders meeting8 Oct 2026
Sotac Pharmaceuticals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 31, 2026
Outcome of Board Meeting8 Oct 2026
Sotac Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on October 08, 2026.
Shareholders meeting1 Oct 2026
Sotac Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Shareholders meeting30 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Trading Window30 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Copy of Newspaper Publication8 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
General Updates8 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange about Regulation 36(1)(b) of the SEBI Listing Regulations regarding letter to shareholders
Record Date8 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.
Shareholders meeting8 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Appointment7 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange regarding Appointment of M/s. Suthar Haresh & Associates, Cost Auditor of the company w.e.f. April 01, 2026.
Outcome of Board Meeting7 Sept 2026
Sotac Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026 regarding approval of Draft Directors Report & Notice of 11th Annual General Meeting of the company
Bagging/Receiving of orders/contracts23 Jul 2026
Sotac Pharmaceuticals Limited has informed the Exchange about Bagging/Receiving of orders/contracts.
Certificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026
Sotac Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Dividend26 May 2026
Sotac Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 26, 2026, recommended Final Dividend of Rs. 0.20 per equity share.
Outcome of Board Meeting26 May 2026
Sotac Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Structural Digital Database25 May 2026
Submission of Structural Digital Database Compliance Certificate under SEBI (Prohibition of Insider Trading) Regulations, 2015, for the year ended 31st March, 2026.
Disclosure under SEBI Takeover Regulations22 May 2026
Sharadkumar Dashrathbhai Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter15 Apr 2026
Sotac Pharmaceuticals Limited has informed regarding Submission of Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended on March 31, 2026.

Frequently Asked Questions

Where can I download the annual report of Sotac Pharmaceuticals Ltd.?

Annual reports of Sotac Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Sotac Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Sotac Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Sotac Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Sotac Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Sotac Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Sotac Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Sotac Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Sotac Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Sotac Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sotac Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Sotac Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Sotac Pharmaceuticals Ltd. is INE0O2D01012. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Sotac Pharmaceuticals Ltd. listed?

Sotac Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is SOTAC and the BSE code is -.

Where can I find the shareholding pattern of Sotac Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Sotac Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Sotac Pharmaceuticals Ltd. on Sharpely?

Share price data for Sotac Pharmaceuticals Ltd. is updated as of 21 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.